�rg�o de concorr�ncia da UE investiga Sanofi por propaganda enganosa contra rival

The European Union's competition authority has launched an investigation into French pharmaceutical company Sanofi for allegedly running a misleading campaign against a rival flu vaccine maker. This move by the antitrust body signals a deeper scrutiny into corporate marketing tactics that could distort fair competition. Such investigations are crucial in maintaining market integrity and ensuring that businesses compete on a level playing field, which ultimately benefits consumers and the overall economy. This probe highlights the ongoing efforts to curb deceptive practices in the competitive pharmaceutical industry.